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Abstract
Background: Synthesizing research evidence using systematic and rigorous methods has become a key feature of evidence-
based medicine and knowledge translation. Systematic reviews (SRs) may or may not include a meta-analysis depending on
the suitability of available data. They are often being criticised as ‘secondary research’ and denied the status of original
research. Scientific journals play an important role in the publication process. How they appraise a given type of research
influences the status of that research in the scientific community. We investigated the attitudes of editors of core clinical
journals towards SRs and their value for publication.
Methods: We identified the 118 journals labelled as ‘‘core clinical journals’’ by the National Library of Medicine, USA in April
2009. The journals’ editors were surveyed by email in 2009 and asked whether they considered SRs as original research
projects; whether they published SRs; and for which section of the journal they would consider a SR manuscript.
Results: The editors of 65 journals (55%) responded. Most respondents considered SRs to be original research (71%) and
almost all journals (93%) published SRs. Several editors regarded the use of Cochrane methodology or a meta-analysis as
quality criteria; for some respondents these criteria were premises for the consideration of SRs as original research. Journals
placed SRs in various sections such as ‘‘Review’’ or ‘‘Feature article’’. Characterization of non-responding journals showed
that about two thirds do publish systematic reviews.
Discussion: Currently, the editors of most core clinical journals consider SRs original research. Our findings are limited by a
non-responder rate of 45%. Individual comments suggest that this is a grey area and attitudes differ widely. A debate about
the definition of ‘original research’ in the context of SRs is warranted.
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Introduction
Since the first comparative study to answer a therapeutic
question by James Lind in the 18
th century [1], the number of
medical research studies is ever increasing. Accordingly, the need
to synthesize research evidence has been recognized for over two
centuries. A more formal approach to systematically synthesizing
the research evidence that accumulates in medical science in a
systematic review was not developed until the late 20
th century and
gained momentum with the advent of evidence-based medicine.
[2] Besides providing a comprehensive overview, systematic
reviews help to identify areas where further research is needed
or, inversely, might be unnecessary or even unethical [3].
Evidence-based medicine has been called a ‘‘new paradigm’’
because it asks questions about health care in an answerable
format and considers the best evidence available from clinical
research. In order to keep abreast of the large quantity of new data
being generated continuously, systematic reviews have become the
central and indispensable tool of evidence-based medicine [4].
In contrast to classical narrative reviews, systematic reviews use
an explicit and rigorous methodology. They start with a clearly
stated set of clinically relevant questions and pre-defined criteria
for study inclusion. The scientific literature is then systematically
searched with the aim of identifying all potentially relevant studies.
After application of eligibility criteria, the included studies are
assessed for their internal validity, in particular the risk of bias. If
possible, data are combined using meta-analytic methods. [5] By
statistically combining information from all or part of the included
studies, meta-analyses can provide pooled estimates that are more
precise than those derived from individual studies. [6] Presence or
absence of a meta-analysis does not represent a quality criterion
since it is directly dependent on the studies identified and data
available for inclusion in the systematic review. Finally, results of
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error and considering external validity or applicability of results.
The general concept of systematic reviews and their method-
ology were originally developed in the social sciences. In medicine
they have been applied predominantly for the evaluation of
treatments. [5] With some adaptations the general methodology of
systematic reviews is also applicable to questions of diagnostic test
accuracy and prognosis. [7–9] Systematic reviews usually provide
more reliable findings than individual studies or non-systematic
narrative reviews. [10–13] Consequently, more robust conclusions
can be drawn which, in turn, may inform decision making on
different levels from individual patient care to the organization of
health care systems.
Over the last 10 to 15 years, the number of published systematic
reviews has increased markedly. [14] When carried out before the
start of new clinical studies, a systematic review can help to
optimize the allocation of limited research resources. Consequent-
ly, leading funding agencies such as the UK Medical Research
Council require systematic reviews as part of grant applications.
[15] Leading medical journals now advocate a systematic overview
of the evidence as part of published reports of new randomized
trials. [16] In recent years the role of research syntheses has been
further strengthened by the decision of the U.S. government in
2009 to allocate $1.1 billion to comparative-effectiveness research
(CER) under the framework of the American Recovery and
Reinvestment Act. [17] The Institute of Medicine (IOM) recently
published two reports which underline the relevance of systematic
review methodology both for CER and evidence-based clinical
practice guidelines [18,19].
Despite these important functions and the recent prominent
government support, the status and value of systematic reviews is
still being disputed in academia. The debate is partly fueled by
persistent misconceptions. [20] In the past, systematic reviews
have been dubbed ‘‘secondary research’’ in contrast to ‘‘primary
or original research’’, implying that they were less scientifically
novel and required less methodological rigor than studies deemed
primary research. Early opponents even spoke of ‘‘mega-silliness’’
and ‘‘statistical alchemy for the 21
st century’’ [21].
At present there is considerable heterogeneity across countries
with regard to both the funding available for systematic reviews
and their academic recognition. While in some countries, such as
the U.K. and The Netherlands, medical faculties have established
professorships and academic units for systematic reviews the
related methods still play only a minor role in medical student
education in other countries. Similarly, the way methods of
research synthesis are adopted and used varies widely across
medical specialty fields.
Scientific journals play an important role in the dissemination of
scientific knowledge by setting quality standards and determining
the way in which research is being published. Journal editors can
thus be considered gatekeepers. How they appraise a given type of
research activity influences the recognition it receives in the
scientific community. Given the influential role of journal editors,
we set out to elucidate their attitudes towards systematic reviews.
In particular, we were interested in the scientific status attributed
to systematic reviews and their acceptability for publication in
clinical journals.
Methods
We identified the 118 core clinical journals as defined by the
National Library of Medicine (USA) as of April 2009 (see File S1).
From the journals’ websites we retrieved the contact details of the
main editorial offices and, if available, of the editors-in-chief. We
sent out a short email questionnaire in April 2009 asking whether
editors would
(1) consider a systematic review manuscript an original research
project
(2) publish a systematic review in their journal, and
(3) in which section of their journal they would publish a
systematic review.
A reminder email was sent in August 2009. For all but two
journals, the editors-in-chief responded to our survey; in the
remaining two journals other editorial staff answered the survey.
Ethics approval was not required since editors-in-chief were free to
participate in our survey and data were anonymized.
Two investigators then independently evaluated and classified
the responses. If discrepancies occurred, consensus was reached in
discussion with a third investigator. We extracted the ISI impact
factor of the included journals from the Journal Citation Report
2009. [22] All data were collated in a spreadsheet in Microsoft
Excel and used for descriptive statistics.
To characterize the group of non-responding journals, we
developed a three step process that entailed 1) a PubMed search
for systematic reviews classified as meta-analyses published in these
journals in 2009, 2) hand-searching the content published in 2009
of journals for which we did not identify a meta-analysis in our
PubMed search, 3) evaluation of author instructions of journals
from point 2 (above) to determine whether they would have
published systematic reviews.
Results
Seventeen (14%) of the 118 journals were general medical
journals and 101 (86%) were specialty journals. The majority of
the journals were published in the USA (Table 1). Editors of 65
journals (55%) responded to our survey. For three journals, not all
questions were answered. The response rate was higher for editors
of general medical journals (13/17; 76%) than for those of
specialty journals (52/101; 52%). We received responses from
50% (51/101) of the U.S. journals and from 80% (12/15) of the
British journals. The median ISI impact factor for responder
journals was 2.99 (range 0.29 – 52.6) and for non-responder
journals 3.61 (range 0.40 – 69.0).
Status of Systematic Reviews
Seventy-one percent (46/65) of editors regarded systematic
reviews as original research projects. Nine of them (29%) did so
only under certain premises (Table 2). For some editors the use of
Cochrane methodology [5] or meta-analytic methods were a
criterion to decide whether a systematic review is considered
original research. For illustration, Table 3 includes some excerpts
from the responses.
Acceptability for Publication
Of 64 respondents, 60 (94%) published systematic reviews
(Table 2). Six (9%) did so only rarely and four (6%) not at all.
About a third of the journals published systematic reviews in a
section dedicated to original research articles and a third in a
specific section for (systematic) reviews. Some journals either
featured them as special articles or placed them in other sections
(Table 2).
Non-responding Journals
Of the 53 journals that did not respond to our survey, 30
(56.6%) published at least one systematic review in 2009, two
Scientific Value of Systematic Reviews
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instructions, while 21 (39.6%) neither published any nor explicitly
mention systematic reviews in their author instructions. Of those
that published systematic reviews, in 18 of the 30 the systematic
reviews were published in journal sections that contained original
research articles.
Discussion
We surveyed editors of core clinical journals and found that
most of them regarded systematic reviews as original research.
Nearly all of the journals represented by these editors published
systematic reviews. The respective comments of the respondents
indicate that this is an ill-defined area. This was mirrored by the
variety of criteria used to decide whether a submitted systematic
review manuscript represented original research or not. For some
respondents, the inclusion of a meta-analysis was the key argument
while others looked at the methods being used.
In our set of core clinical journals the general attitude towards
systematic reviews was rather positive. It is conceivable that a
broader sample of biomedical journals, e.g., including basic
sciences journals, would have yielded a more conservative picture.
The main limitation of our survey is that about 45% of the
contacted journals did not respond which could potentially
significantly change the results and affect the interpretation. While
the proportion of non-responding journals that published
systematic reviews was lower, the majority still published at least
one in 2009. Interestingly, more than half of the non-responder
journals that published systematic reviews seemed to consider
them original research. If one assumes that the non-responding
editors are more skeptical about systematic reviews than those who
responded then the results may be less positive overall.
From the large spectrum of responses we conclude that a debate
about the status and the academic recognition of systematic
reviews is warranted. A next step should be an in-depth analysis of
the views of different stakeholders including researchers, funders,
Table 1. Journal characteristics by survey responder status.
JOURNAL CHARACTERISTICS RESPONDERS NON-RESPONDERS TOTAL
N=65 (55%) N=53 (45%) N=118
Type of journal
General medical journal* 13 (76%) 4 (24%) 17
(Sub-) Speciality journal** 52 (52%) 49 (48%) 101
Country of publication
USA 51 (50%) 50 (50%) 101
United Kingdom 12 (80%) 3 (20%) 15
Other 2 (100%) 0 (0%) 2
Journal impact factor
JCR 2007 - median (range) 2.99 (0.29–52.59) 3.60 (0.37–69.03) 3.23 (0.29–69.03)
*e.g. JAMA, BMJ, NEJM;
**e.g., Annals of Surgery, Chest, Rheumatology.
doi:10.1371/journal.pone.0035732.t001
Table 2. Status of systematic reviews – results of survey of journal editors.
SURVEY QUESTION ANSWERS N=65
1. ‘‘Do you consider a systematic review an original research project?’’ Yes: 37 (57%)
Under premises: 9 (14%)
No: 19 (29%)
2. ‘‘Do you publish systematic reviews in your journal?’’ Yes: 54 (83%)
Rarely: 6 (9%)
No: 4 (6%)
Answer missing: 1 (2%)
3. ‘‘For which section would you consider a manuscript reporting
on a systematic review?’’*
(Systematic) review: 23 (35%)
(Original) research: 18 (28%)
Special article: 9 (14%)
By topic: 9 (14%)
Does not apply: 5 (8%)
Answer missing: 3 (5%)
*multiple answers possible.
doi:10.1371/journal.pone.0035732.t002
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editors.
Ideally, the clinical research community would accept system-
atic reviews as a research category of its own, which is defined by
methodological criteria, as is the case for other types of research.
With certain quality criteria being fulfilled, systematic reviews
should not be denied the appropriate academic recognition they
deserve. Under these premises their scientific value should be on
par with conventional original research studies. This argument
becomes even more compelling when one considers that
systematic reviews are essentially observational studies of aggre-
gate or individual data from previous studies.
Due to the continuous work of The Cochrane Collaboration
and other international institutions and networks, the use and
recognition of systematic reviews has increased considerably over
the last 15 years. [4] However, the limited funding opportunities
available for systematic review projects represent a main barrier to
an even wider implementation. A clarification of the scientific
status of systematic reviews might motivate researchers to
undertake such projects to an even larger extent. If high-quality
systematic reviews are accepted as valid research projects by the
research community, then funding agencies might also be more
open to financially support them e.g. by creating specific grant
schemes.
In conclusion, the attitudes of editors of clinical journals vary
with regard to the value given to systematic reviews. Most
responding editors regarded systematic reviews as original research
projects based on varying criteria. This interpretation is limited by
a non-responder rate of 45%. A debate about the scientific value of
systematic reviews and their academic recognition is warranted
and would help establish sustainable programs of evidence
synthesis across countries and different fields of clinical research.
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